Author

Anita Kumari

Translational Health Science and Technology InstituteORCID 0000-0002-7168-576XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Anita Kumari1 paper · University of Delhi

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Akash BagheliD· 1 shared Kritida Dhar· 1 shared Lokesh Kumar· 1 shared Phulwanti Kumari SharmaiD· 1 shared Pradipta JanaiD· 1 shared Rajni YadaviD· 1 shared Ruby Bansal· 1 shared Ruchi Tandon· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Akash BaghelORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintJan 27, 2026

Gut microbiota-derived indole-3 acetic acid mitigates key hallmarks of metabolic dysfunction-associated steatotic liver disease (MASLD) in an NLRP3-dependent manner in in vitro and diet-induced mouse models

Phulwanti Kumari Sharma, Lokesh Kumar, Akash Baghel…·Ruchi Tandon

This study identifies indole-3 acetic acid (I3A) as an NLRP3 inflammasome inhibitor that mitigates MASLD hallmarks in vitro and in diet-induced mouse models.

1 citation

mousebulk RNA-seq

𝕏 PostBluesky